Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination

American Journal of Public Health

Volumn 100, Issue 6, 2010, Pages 1116-1122

  Donahue, James G ^a   Kieke, Burney A ^a   Gargiullo, Paul M ^b   Jumaan, Aisha O ^c   Berger, Nicholas R ^a   McCauley, Jeremy S ^a   Belongia, Edward A ^a  

^a MARSHFIELD CLINIC   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Program for Appropriate Technology in Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; FAMILY; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; RISK; STATISTICS; UNITED STATES; VARICELLA ZOSTER VIRUS;

ADULT; AGED; CASE-CONTROL STUDIES; CHICKENPOX VACCINE; CHILD; FAMILY; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; REGRESSION ANALYSIS; WISCONSIN;

EID: 77952276406     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.160002     Document Type: Article

References (37)

1. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361-381.
2. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
4. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4(1):26-33.
5. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-611.
6. 6. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19-20):2500-2507. (Pubitemid 34615588)
7. 7. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003;70(suppl 1):S31-S37. (Pubitemid 36368842)
8. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002; 360(9334):678-682.
9. Heininger U, Seward JF. Varicella. Lancet. 2006; 368(9544):1365-1376.
10. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993;92(6):833-837.
11. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics. 1993;91(1): 17-22.
12. 12. DeStefano F, Eaker ED, Broste SK, et al. Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol. 1996;49(6):643-652. (Pubitemid 26202692)
13. 13. Greenlee RT, Naleway AL, Vidaillet H. Incidence of myocardial infarction in a general population: the Marshfield Epidemiologic Study Area. WMJ. 2002; 101(7):46-52. (Pubitemid 35239774)
14. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
15. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 1998.
16. Walker AM. Observation and Inference. An Introduction to the Methods of Epidemiology. Newton Lower Falls, MA: Epidemiology Resources Inc; 1991.
17. Hastie TJ, Tibshirani RJ. Generalized Additive Models. New York, NY: Chapman and Hall; 1990.
18. Chaves SS, Santibanez TA, Gargiullo P, Guris D. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep. 2007;122(2):155-159.
19. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996;45(RR-11):1-36.
20. Luman ET, Ching PL, Jumaan AO, Seward JF. Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities. Pediatrics. 2006;117(4):999-1008.
21. Centers for Disease Control and Prevention. Decline in annual incidence of varicella-selected states, 1990-2001. MMWR Morb Mortal Wkly Rep. 2003;52(37): 884-885.
22. Brisson M, Edmunds WJ. Epidemiology of varicellazoster virus in England and Wales. J Med Virol. 2003; 70(suppl 1):S9-S14.
23. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356:1121-1129.
24. Vázquez M. Varicella infections and varicella vaccine in the 21st century. Pediatr Infect Dis J. 2004; 23(9):871-872.
25. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133:245-253.
26. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun. 1981;32(1):24-27.
27. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352(22):2266-2267.
28. Schlesselman JJ. Case-Control Studies. Design, Conduct, Analysis. Vol 1. New York, NY: Oxford University Press; 1982.
29. Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996;173(2):450-453.
30. Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med. 2000;6(4):451-454.
31. Gershon AA, Steinberg SP, Borkowsky W, Lennette D, Lennette E. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster. Pediatr Infect Dis. 1982;1(3):164-167.
32. Klein NP, Holmes TH, Sharp MA, et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine. 2006; 24:5913-5918.
33. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991;325(22):1545-1550.
34. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination--associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005; 191(12):2002-2007.
35. Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J Am Acad Dermatol. 1998; 38(5 pt 1):763-765.
36. Terada K, Hiraga Y, Kawano S, Kataoka N. Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster [in Japanese]. Kansenshogaku Zasshi. 1995; 69(8):908-912.
37. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284.